HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Md Asaduzzaman Khan Selected Research

thymoquinone

6/2022Thymoquinone upregulates IL17RD in controlling the growth and metastasis of triple negative breast cancer cells in vitro.
1/2022Synergistic Role of Thymoquinone on Anticancer Activity of 5-Fluorouracil in Triple Negative Breast Cancer Cells.
1/2022Cordycepin Inhibits Triple-Negative Breast Cancer Cell Migration and Invasion by Regulating EMT-TFs SLUG, TWIST1, SNAIL1, and ZEB1.
8/2021Thymoquinone against infectious diseases: Perspectives in recent pandemics and future therapeutics.
2/2021Thymoquinone in autoimmune diseases: Therapeutic potential and molecular mechanisms.
1/2021Targeting Inflammatory Mediators: An Anticancer Mechanism of Thymoquinone Action.
1/2021Biological Role of AKT and Regulation of AKT Signaling Pathway by Thymoquinone: Perspectives in Cancer Therapeutics.
12/2020Targeting kinases with thymoquinone: a molecular approach to cancer therapeutics.
12/2019Epigenetic role of thymoquinone: impact on cellular mechanism and cancer therapeutics.
12/2017Thymoquinone Inhibits the Migration and Invasive Characteristics of Cervical Cancer Cells SiHa and CaSki In Vitro by Targeting Epithelial to Mesenchymal Transition Associated Transcription Factors Twist1 and Zeb1.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Md Asaduzzaman Khan Research Topics

Disease

28Neoplasms (Cancer)
07/2022 - 10/2010
11Neoplasm Metastasis (Metastasis)
06/2022 - 10/2010
6Carcinogenesis
01/2022 - 03/2017
5Breast Neoplasms (Breast Cancer)
01/2022 - 01/2016
4Triple Negative Breast Neoplasms
06/2022 - 09/2021
4Cicatrix (Scar)
08/2020 - 01/2013
3Inflammation (Inflammations)
01/2022 - 10/2013
3Uterine Cervical Neoplasms (Cancer of the Cervix)
01/2019 - 08/2013
2Hepatocellular Carcinoma (Hepatoma)
01/2022 - 01/2021
2Prostatic Neoplasms (Prostate Cancer)
01/2022 - 07/2019
2Infections
08/2021 - 08/2021
2Carcinoma (Carcinomatosis)
06/2013 - 02/2011
1Type 1 Diabetes Mellitus (Autoimmune Diabetes)
01/2022
1Communicable Diseases (Infectious Diseases)
08/2021
1Autoimmune Diseases (Autoimmune Disease)
02/2021
1Neurodegenerative Diseases (Neurodegenerative Disease)
01/2021
1Cardiovascular Diseases (Cardiovascular Disease)
01/2021
1COVID-19
01/2020
1Retinitis Pigmentosa (Pigmentary Retinopathy)
01/2015
1Autistic Disorder (Autism)
10/2014
1Human Influenza (Influenza)
10/2013
1Wounds and Injuries (Trauma)
10/2013
1Lung Neoplasms (Lung Cancer)
06/2013
1Genetic Predisposition to Disease (Genetic Predisposition)
06/2013

Drug/Important Bio-Agent (IBA)

12thymoquinoneIBA
06/2022 - 01/2011
9Proteins (Proteins, Gene)FDA Link
07/2022 - 10/2010
6EnzymesIBA
07/2022 - 02/2011
6AntioxidantsIBA
01/2022 - 03/2013
5Pharmaceutical PreparationsIBA
12/2021 - 12/2011
5DNA (Deoxyribonucleic Acid)IBA
10/2015 - 02/2011
4Transcription Factors (Transcription Factor)IBA
01/2022 - 08/2014
4Biological ProductsIBA
01/2022 - 10/2014
3Cytochrome P-450 CYP1A1 (CYP1A1)IBA
07/2022 - 02/2011
3cordycepinIBA
01/2022 - 01/2019
3Mitogen-Activated Protein KinasesIBA
12/2020 - 08/2014
2Cell Cycle ProteinsIBA
07/2022 - 01/2019
2PhytochemicalsIBA
01/2022 - 08/2021
2VaccinesIBA
01/2022 - 08/2021
2Reactive Oxygen Species (Oxygen Radicals)IBA
01/2021 - 11/2019
2Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
01/2021 - 11/2019
2Phosphotransferases (Kinase)IBA
01/2021 - 12/2020
2Matrix Metalloproteinases (MMPs)IBA
11/2019 - 08/2014
2Cadherins (E-Cadherin)IBA
12/2017 - 08/2014
2Cytochrome P-450 CYP2D6 (CYP2D6)IBA
06/2013 - 02/2011
1HLA-DRB1 Chains (HLA DRB1)IBA
07/2022
1Cytochrome P-450 CYP3AIBA
07/2022
1Cdh1 ProteinsIBA
07/2022
1XenobioticsIBA
07/2022
1MelatoninIBA
01/2022
1Ethanol (Ethyl Alcohol)IBA
01/2022
1Fluorouracil (Carac)FDA LinkGeneric
01/2022
1Gallic AcidIBA
01/2022
1Insulin (Novolin)FDA Link
01/2022
1Toll-Like Receptors (Toll-Like Receptor)IBA
01/2022
1Pattern Recognition ReceptorsIBA
01/2022
1PowdersIBA
01/2022
1naphthaIBA
01/2022
1RNA (Ribonucleic Acid)IBA
01/2022
1NF-kappa B (NF-kB)IBA
01/2022
1buteinIBA
12/2021
1Chalcone (Benzalacetophenone)IBA
12/2021
1GoldIBA
09/2021
1Soaps (Soap)IBA
08/2021
1FlavonoidsIBA
01/2021
1Tyrosine (L-Tyrosine)FDA Link
01/2021
1folinIBA
01/2021
1Polo-Like Kinase 1IBA
12/2020
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
12/2020
1Janus KinasesIBA
12/2020
1Phosphatidylinositols (Phosphatidylinositol)IBA
12/2020
1NucleotidesIBA
08/2020
1HesperidinIBA
01/2020
1Histones (Histone)IBA
12/2019
1Protein Kinases (Protein Kinase)IBA
11/2019
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
11/2019
1JNK Mitogen-Activated Protein KinasesIBA
11/2019
1Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA
11/2019
1Ubiquitin-Specific ProteasesIBA
07/2019
1Deubiquitinating EnzymesIBA
07/2019
1HydrolasesIBA
07/2019
1Androgen Receptors (Androgen Receptor)IBA
07/2019
1Ubiquitin CIBA
07/2019
1Biomarkers (Surrogate Marker)IBA
01/2017
1Twist-Related Protein 1IBA
01/2016
1Plant ExtractsIBA
10/2015
1Retinaldehyde (Retinal)IBA
01/2015
1STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA
08/2014
1VimentinIBA
08/2014
1Hypnotics and Sedatives (Sedatives)IBA
06/2014
1ConvulsantsIBA
06/2014
1Anti-Anxiety Agents (Anxiolytics)IBA
06/2014
1Basic Helix-Loop-Helix Transcription FactorsIBA
10/2013
1Polysaccharides (Glycans)IBA
05/2013
1GlucansIBA
05/2013
1ResveratrolIBA
03/2013

Therapy/Procedure

13Therapeutics
01/2022 - 08/2013
2Drug Therapy (Chemotherapy)
01/2022 - 01/2022
1Stem Cell Transplantation
01/2022
1Castration
07/2019
1Traditional Medicine (Folk Remedies)
10/2013